Shō-saiko-tō (小柴胡湯), also known as minor bupuleurum formula and xiǎocháihútāng (XCHT) (Chinese: 小柴胡湯), is a herbal supplement, believed to enhance liver health.
There are currently ongoing clinical trials for Sho-Saiko-To at University of California, San Diego and Memorial Sloan-Kettering Cancer Center.
The active ingredients of sho-saiko-to discovered so far include baicalin, baicalein, glycyrrhizin, saikosaponins, ginsenosides, wogonin, and gingerol.
[citation needed] As a Chinese patent medicine it is listed in the Pharmacopoeia of the People's Republic of China.
[2] It is first recorded in Shanghan Lun c. 220 AD, indicated for "lesser yang".